Outcomes of Malignant CNS Ependymomas: An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973-2005)

Dayron Rodríguez, Michael C. Cheung, Nadine Housri, Alfredo Quinones-Hinojosa, Kevin Camphausen, Leonidas G. Koniaris

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background: Determine the role of surgery and radiation therapy for patients with malignant CNS ependymomas. Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, a total of 2408 cases of malignant ependymomas were identified. Of these, 2132 cases (88.5%) were identified as WHO grade II ependymomas and 276 cases (11.5%) as WHO grade III (anaplastic) ependymomas. The annual incidence of ependymomas was approximately 1.97 cases per million in 2005. Overall median survival for all patients was 230 mo, with a significant difference between women and men (262 mo versus196 mo, respectively) (P = 0.004). Median age at diagnosis was 37 y among females and 34 y in males. Patients who successfully underwent surgical resection had a considerably longer median survival (237 mo versus 215 mo, P < 0.001) as well as a significantly improved five-year survival (72.4% versus 52.6%, P < 0.001). Univariate analysis demonstrated that age, gender, ethnicity, primary tumor site, WHO grade and surgical resection were significant predictors of improved survival for ependymoma patients. Multivariate analysis identified that a WHO grade III tumor, male gender, patient age, intracranial tumor locations and failure to undergo surgical resection were independent predictors of poorer outcomes. Multivariate analysis of partially resection cases revealed that lack of radiation was a sign of poor prognosis (HR 1.748, P = 0.024). Conclusion: Surgical extirpation of ependymomas is associated with significantly improved patient survival. For partially resected tumors, radiation therapy provides significant survival benefit.

Original languageEnglish (US)
Pages (from-to)340-351
Number of pages12
JournalJournal of Surgical Research
Volume156
Issue number2
DOIs
StatePublished - Oct 1 2009

Fingerprint

Ependymoma
Epidemiology
Databases
Survival
Neoplasms
Radiotherapy
Multivariate Analysis
Radiation
Incidence

Keywords

  • SEER
  • cancer
  • ependymoma
  • malignancy
  • outcomes
  • radiation
  • surgery
  • survival

ASJC Scopus subject areas

  • Surgery

Cite this

Outcomes of Malignant CNS Ependymomas : An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973-2005). / Rodríguez, Dayron; Cheung, Michael C.; Housri, Nadine; Quinones-Hinojosa, Alfredo; Camphausen, Kevin; Koniaris, Leonidas G.

In: Journal of Surgical Research, Vol. 156, No. 2, 01.10.2009, p. 340-351.

Research output: Contribution to journalArticle

Rodríguez, Dayron ; Cheung, Michael C. ; Housri, Nadine ; Quinones-Hinojosa, Alfredo ; Camphausen, Kevin ; Koniaris, Leonidas G. / Outcomes of Malignant CNS Ependymomas : An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973-2005). In: Journal of Surgical Research. 2009 ; Vol. 156, No. 2. pp. 340-351.
@article{019407d5b03048f7a5a49e4a60314d2c,
title = "Outcomes of Malignant CNS Ependymomas: An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973-2005)",
abstract = "Background: Determine the role of surgery and radiation therapy for patients with malignant CNS ependymomas. Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, a total of 2408 cases of malignant ependymomas were identified. Of these, 2132 cases (88.5{\%}) were identified as WHO grade II ependymomas and 276 cases (11.5{\%}) as WHO grade III (anaplastic) ependymomas. The annual incidence of ependymomas was approximately 1.97 cases per million in 2005. Overall median survival for all patients was 230 mo, with a significant difference between women and men (262 mo versus196 mo, respectively) (P = 0.004). Median age at diagnosis was 37 y among females and 34 y in males. Patients who successfully underwent surgical resection had a considerably longer median survival (237 mo versus 215 mo, P < 0.001) as well as a significantly improved five-year survival (72.4{\%} versus 52.6{\%}, P < 0.001). Univariate analysis demonstrated that age, gender, ethnicity, primary tumor site, WHO grade and surgical resection were significant predictors of improved survival for ependymoma patients. Multivariate analysis identified that a WHO grade III tumor, male gender, patient age, intracranial tumor locations and failure to undergo surgical resection were independent predictors of poorer outcomes. Multivariate analysis of partially resection cases revealed that lack of radiation was a sign of poor prognosis (HR 1.748, P = 0.024). Conclusion: Surgical extirpation of ependymomas is associated with significantly improved patient survival. For partially resected tumors, radiation therapy provides significant survival benefit.",
keywords = "SEER, cancer, ependymoma, malignancy, outcomes, radiation, surgery, survival",
author = "Dayron Rodr{\'i}guez and Cheung, {Michael C.} and Nadine Housri and Alfredo Quinones-Hinojosa and Kevin Camphausen and Koniaris, {Leonidas G.}",
year = "2009",
month = "10",
day = "1",
doi = "10.1016/j.jss.2009.04.024",
language = "English (US)",
volume = "156",
pages = "340--351",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Outcomes of Malignant CNS Ependymomas

T2 - An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973-2005)

AU - Rodríguez, Dayron

AU - Cheung, Michael C.

AU - Housri, Nadine

AU - Quinones-Hinojosa, Alfredo

AU - Camphausen, Kevin

AU - Koniaris, Leonidas G.

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Background: Determine the role of surgery and radiation therapy for patients with malignant CNS ependymomas. Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, a total of 2408 cases of malignant ependymomas were identified. Of these, 2132 cases (88.5%) were identified as WHO grade II ependymomas and 276 cases (11.5%) as WHO grade III (anaplastic) ependymomas. The annual incidence of ependymomas was approximately 1.97 cases per million in 2005. Overall median survival for all patients was 230 mo, with a significant difference between women and men (262 mo versus196 mo, respectively) (P = 0.004). Median age at diagnosis was 37 y among females and 34 y in males. Patients who successfully underwent surgical resection had a considerably longer median survival (237 mo versus 215 mo, P < 0.001) as well as a significantly improved five-year survival (72.4% versus 52.6%, P < 0.001). Univariate analysis demonstrated that age, gender, ethnicity, primary tumor site, WHO grade and surgical resection were significant predictors of improved survival for ependymoma patients. Multivariate analysis identified that a WHO grade III tumor, male gender, patient age, intracranial tumor locations and failure to undergo surgical resection were independent predictors of poorer outcomes. Multivariate analysis of partially resection cases revealed that lack of radiation was a sign of poor prognosis (HR 1.748, P = 0.024). Conclusion: Surgical extirpation of ependymomas is associated with significantly improved patient survival. For partially resected tumors, radiation therapy provides significant survival benefit.

AB - Background: Determine the role of surgery and radiation therapy for patients with malignant CNS ependymomas. Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, a total of 2408 cases of malignant ependymomas were identified. Of these, 2132 cases (88.5%) were identified as WHO grade II ependymomas and 276 cases (11.5%) as WHO grade III (anaplastic) ependymomas. The annual incidence of ependymomas was approximately 1.97 cases per million in 2005. Overall median survival for all patients was 230 mo, with a significant difference between women and men (262 mo versus196 mo, respectively) (P = 0.004). Median age at diagnosis was 37 y among females and 34 y in males. Patients who successfully underwent surgical resection had a considerably longer median survival (237 mo versus 215 mo, P < 0.001) as well as a significantly improved five-year survival (72.4% versus 52.6%, P < 0.001). Univariate analysis demonstrated that age, gender, ethnicity, primary tumor site, WHO grade and surgical resection were significant predictors of improved survival for ependymoma patients. Multivariate analysis identified that a WHO grade III tumor, male gender, patient age, intracranial tumor locations and failure to undergo surgical resection were independent predictors of poorer outcomes. Multivariate analysis of partially resection cases revealed that lack of radiation was a sign of poor prognosis (HR 1.748, P = 0.024). Conclusion: Surgical extirpation of ependymomas is associated with significantly improved patient survival. For partially resected tumors, radiation therapy provides significant survival benefit.

KW - SEER

KW - cancer

KW - ependymoma

KW - malignancy

KW - outcomes

KW - radiation

KW - surgery

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=70249092498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249092498&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2009.04.024

DO - 10.1016/j.jss.2009.04.024

M3 - Article

C2 - 19577759

AN - SCOPUS:70249092498

VL - 156

SP - 340

EP - 351

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -